(Q36485625)

14 August 2017

1 reference

title

Somatostatin and analogues in the treatment of cancer. A review (English)

1 reference

14 August 2017

Somatostatin and Analogues in the Treatment of Cancer (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1097/00000658-199103000-00002

25 October 2022

1 reference

https://api.crossref.org/works/10.1097/00000658-199103000-00002

25 October 2022

C M Townsend

1 reference

14 August 2017

B M Evers

1 reference

14 August 2017

D. Parekh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671812

25 October 2022

J. C. Thompson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671812

25 October 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

full work available at URL

14 August 2017

http://journals.lww.com/00000658-199103000-00002

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1097/00000658-199103000-00002

25 October 2022

1 reference

14 August 2017

volume

213

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

190-198

1 reference

NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.

14 August 2017

cites work

1 reference

12 December 2020

Clinical significance of gastrin receptors in human colon cancers.

1 reference

12 December 2020

Somatostatin analogue (SMS 201-995) in patients with gastrinomas

1 reference

12 December 2020

Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines

1 reference

12 December 2020

Oncological applications of somatostatin analogues

1 reference

12 December 2020

1 reference

12 December 2020

Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers

1 reference

12 December 2020

Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin

1 reference

12 December 2020

Bombesin-like peptides and receptors in human tumor cell lines

1 reference

12 December 2020

Small cell lung cancer: Analysis of treatment factors contributing to prolonged survival

1 reference

12 December 2020

Mammalian bombesin-like peptides: neuromodulators of gastric function and autocrine regulators of lung cancer growth

1 reference

12 December 2020

Endogenous somatostatin and the gut.

1 reference

12 December 2020

Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones

1 reference

12 December 2020

Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.

1 reference

12 December 2020

A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.

1 reference

12 December 2020

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin

1 reference

12 December 2020

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

1 reference

12 December 2020

Regression of liver metastases in patient with gastrin-secreting tumour treated with SMS 201-995

1 reference

12 December 2020

Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995

1 reference

12 December 2020

Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome

1 reference

12 December 2020

Human lung small-cell carcinoma contains bombesin

1 reference

12 December 2020

Bombesin production by human small cell carcinoma of the lung

1 reference

12 December 2020

Immunocytochemical localization of insulin- and somatostatin-like material in human breast tumors

1 reference

12 December 2020

Circulatory effects of somatostatin in anesthetized man

1 reference

12 December 2020

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1 reference

12 December 2020

Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1

1 reference

12 December 2020

Hormonal control of pancreatic cancer growth

1 reference

12 December 2020

Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa-2 cell line

1 reference

12 December 2020

Autocrine and paracrine growth regulation of human breast cancer

1 reference

12 December 2020

Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer

1 reference

12 December 2020

Effects of bombesin on growth of human small cell lung carcinoma in vivo

1 reference

12 December 2020

Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a

1 reference

12 December 2020

Secretion of somatostatin and its physiologic function

1 reference

12 December 2020

Effective and lasting growth-hormone suppression in active acromegaly with oral administration of somatostatin analogue SMS 201-995.

1 reference

12 December 2020

Effects of somatostatin analogue SMS 201-995 in normal man

1 reference

12 December 2020

Immunoreactive and biologically active somatostatin in human and sheep milk

1 reference

12 December 2020

Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog.

1 reference

12 December 2020

Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases

1 reference

12 December 2020

Regression of metastatic vipoma with somatostatin analogue SMS 201-995

1 reference

12 December 2020

Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin

1 reference

12 December 2020

Bombesin-like peptides in human small cell carcinoma of the lung

1 reference

12 December 2020

Somatostatin receptors in human endocrine tumors

1 reference

12 December 2020

Dietary fiber and peptic ulcer

1 reference

12 December 2020

Gastrointestinal endocrine tumors

1 reference

12 December 2020

Somatostatin and analogues in the treatment of VIPoma

1 reference

12 December 2020

In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue

1 reference

12 December 2020

Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.

1 reference

12 December 2020

Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion

1 reference

12 December 2020

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer

1 reference

12 December 2020

Somatostatin and octreotide: literature review and description of therapeutic activity in pancreatic neoplasia

1 reference

12 December 2020

Potential role of somatostatin analogues in the treatment of cancer

1 reference

12 December 2020

Somatostatin analogue SMS 201-995 long term therapy for vipoma

1 reference

12 December 2020

Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome

1 reference

12 December 2020

SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years

1 reference

12 December 2020

Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH

1 reference

12 December 2020

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

1 reference

12 December 2020

Gastrin stimulates growth of colon cancer

1 reference

12 December 2020

Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

1 reference

12 December 2020

Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor

1 reference

12 December 2020

Somatostatin (second of two parts).

1 reference

12 December 2020

Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma

1 reference

12 December 2020

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

12 December 2020

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

12 December 2020

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

1 reference

12 December 2020

Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome

1 reference

12 December 2020

Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas

1 reference

12 December 2020

Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts

1 reference

12 December 2020

Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors

1 reference

12 December 2020

Identifiers

DOI

1 reference

National Center for Biotechnology Information

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1671812

25 October 2022

1 reference